You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sentinel Dosing

Showing 1 - 25 of 6,058
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dengue Trial in Baltimore, Burlington (JNJ-64281802 (sentinel high dose), JNJ-64281802 (remaining high dose), JNJ-64281802

Recruiting
  • Dengue
  • JNJ-64281802 (sentinel high dose)
  • +6 more
  • Baltimore, Maryland
  • +1 more
May 11, 2022

Healthy Trial (SSS40, Placebo)

Not yet recruiting
  • Healthy
  • (no location specified)
Aug 27, 2023

Healthy Trial in Dallas (NM8074, Placebo)

Completed
  • Healthy
  • Dallas, Texas
    Covance Clinical Unit
Nov 29, 2022

Pulmonary Arterial Hypertension Trial in Adelaide (L608 Inhalation Solution, Placebo solution)

Not yet recruiting
  • Pulmonary Arterial Hypertension
  • L608 Inhalation Solution
  • Placebo solution
  • Adelaide, South Australia, Australia
    CMAX Clinical Research Pty Ltd
Jul 12, 2023

Chikungunya Virus Infection Trial in Lenexa, Durham (Placebo, SAR440894)

Recruiting
  • Chikungunya Virus Infection
  • Placebo
  • SAR440894
  • Lenexa, Kansas
  • +1 more
Aug 18, 2022

Influenza Trial in Durham (Influenza Virus Quadrivalent Inactivated Vaccine, Sodium Chloride, 0.9%, VRC-FLUNPF099-00-VP

Not yet recruiting
  • Influenza
  • Influenza Virus Quadrivalent Inactivated Vaccine
  • +2 more
  • Durham, North Carolina
    Duke Human Vaccine Institute - Duke Vaccine and Trials Unit
Feb 23, 2023

Healthy Volunteer Trial in Lincoln (DISC-3405, Placebo)

Not yet recruiting
  • Healthy Volunteer
  • Lincoln, Nebraska
    Celerion
Sep 18, 2023

Campylobacter Infection Trial in Cincinnati (ALFQ, CJCV2)

Not yet recruiting
  • Campylobacter Infection
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center - Infectious Disea
Aug 11, 2022

COVID-19 Trial in United States (mRNA-CR-04 vaccine 10µg, mRNA-CR-04 vaccine 30µg, mRNA-CR-04 vaccine 100µg)

Not yet recruiting
  • COVID-19
  • mRNA-CR-04 vaccine 10μg
  • +3 more
  • San Diego, California
  • +3 more
Aug 1, 2023

Chronic Leg Ulcer, Venous Leg Ulcer Trial in Copenhagen (SoftOx Biofilm Eradicator (Groups 1 to 7), Sterile isotonic saline

Completed
  • Chronic Leg Ulcer
  • Venous Leg Ulcer
  • SoftOx Biofilm Eradicator (Groups 1 to 7)
  • Sterile isotonic saline (Groups 1 to 4)
  • Copenhagen, Denmark
    Bispebjerg University Hospital
Jan 24, 2023

To Reduce the LDL-C Level in Hypercholesteremia Adult Patients, Combination for Subgroup High LDL-c Patients With Other

Not yet recruiting
  • To Reduce the LDL-C Level in Hypercholesteremia Adult Patients
  • Combination for Subgroup High LDL-c Patients With Other Comorbidities
  • RN0191 INJECTION
  • (no location specified)
Jun 14, 2023

Pain, Acute Pain Trial in Overland Park (SBS-1000, Placebo)

Recruiting
  • Pain
  • Acute Pain
  • Overland Park, Kansas
    Altasciences Clinical Kansas
Jan 31, 2023

Parkinson Disease Trial in Nottingham (NM-101, Placebo)

Not yet recruiting
  • Parkinson Disease
  • Nottingham, United Kingdom
    Quotient Sciences
Mar 16, 2023

Rhizomelic Chondrodysplasia Punctata Trial in Toronto (PPI-1011, Placebo)

Recruiting
  • Rhizomelic Chondrodysplasia Punctata
  • Toronto, Ontario, Canada
    Biopharma Services Inc.
Jul 23, 2023

Healthy Volunteers Trial in Madison (RO7223280)

Recruiting
  • Healthy Volunteers
  • Madison, Wisconsin
    Covance Clinical Research Unit, Inc
Jan 9, 2023

IgA Nephropathy, Focal Segmental Glomerulosclerosis Trial in Nanjing (HS-10390 tablet, Placebo tablet)

Recruiting
  • IgA Nephropathy
  • Focal Segmental Glomerulosclerosis
  • HS-10390 tablet
  • Placebo tablet
  • Nanjing, Jiangsu, China
    Zhongda Hospital, Affiliated to Southeast University
Jul 12, 2023

Colorectal Cancer Trial in Nottingham (FMPV-1, GM-CSF (as adjuvant))

Active, not recruiting
  • Colorectal Cancer
  • FMPV-1
  • GM-CSF (as adjuvant)
  • Nottingham, United Kingdom
    Quotient Sciences
Nov 29, 2022

Atopic Dermatitis Trial in Seoul (NCP112)

Completed
  • Atopic Dermatitis
  • Seoul, Korea, Republic of
    Severance Hospital
Dec 15, 2022

Coccidioidomycosis Trial in San Antonio (Placebo, VT-1598)

Completed
Has Results
  • Coccidioidomycosis
  • San Antonio, Texas
    ICON Early Phase Services Clinical Research Unit
Dec 15, 2022

Healthy Participants Trial (ALXN1920, Placebo)

Not yet recruiting
  • Healthy Participants
  • ALXN1920
  • Placebo
  • (no location specified)
Feb 21, 2023

Type 2 Diabetes Trial in Glendale (AZD0186, Placebo)

Recruiting
  • Type 2 Diabetes
  • Glendale, California
    Research Site
Jan 12, 2023

Breast Cancer, DCIS, Invasive Duct Carcinoma of Breast Trial in Scottsdale (LS301-IT 0.025 mg/kg, LS301-IT 0.05 mg/kg, LS301-IT

Not yet recruiting
  • Breast Cancer
  • +2 more
  • LS301-IT 0.025 mg/kg
  • +3 more
  • Scottsdale, Arizona
    Integro Theranostics Research Site #1
Jun 2, 2023

Healthy Trial in Turku (KAND567, Placebo)

Completed
  • Healthy
  • Turku, Finland
    Clinical Research Services Turku (CRST)
Sep 1, 2023

Malaria Trial in Baltimore (MAM01, Placebo)

Not yet recruiting
  • Malaria
  • MAM01
  • Placebo
  • Baltimore, Maryland
    Center for Vaccine Development and Global Health, 685 W. Baltimo
May 26, 2023

Safety Issues, Tolerance Trial in Melbourne (CVN766)

Completed
  • Safety Issues
  • Tolerance
  • Melbourne, Victoria, Australia
    Nucleus Network
Nov 21, 2022